Cryoport Systems Honored at the Asia Pacific Biopharma Excellence Awards 

Cryoport Systems is pleased to announce that we have been awarded Best Logistics & Supply Chain Management Supplier – Digital Technology & Software at the Asia Pacific Biopharma Excellence Awards 2026, held March 11 in Singapore. This recognition reflects both the progress of our organization and the growing importance of dependable, technology-driven support in the development and delivery of advanced therapies across the region.  

This award aligns with a pivotal moment for the Asia-Pacific biopharma landscape as a whole, and advanced therapies in particular. As more clinical programs move into late-stage development and commercial scale, the need for predictable and transparent logistics and supply chain solutions has never been higher. Our teams across the region (and the global teams who support them) have worked to meet these expectations with systems that provide end-to-end visibility and protection from the point of collection through last-mile delivery.  

The awards ceremony took place at the Sands Expo & Convention Centre, bringing together leaders from cell and gene therapy programs, biologics manufacturers, research institutions, and supply chain partners. The event was a powerful reminder of the shared commitment across the industry to support the expansion of patient access. For us, the recognition underscores the role Cryoport Systems plays in improving reliability and reducing risk in the handling of sensitive materials, Enabling the Outcome™ for our clients and the patients they serve.  

This award specifically highlights our digital technology and software solutions, an area where Cryoport Systems has invested heavily. As organizations seek to simplify complexity and minimize variability, our integrated Cryoportal^® logistics management platform unifies scheduling, tracking, condition monitoring, and Chain of Compliance^® documentation and processes. These capabilities are central to supporting advanced therapies. Across Asia-Pacific and around the world, we’ve seen customers increasingly adopt digital workflows to strengthen oversight and reduce operational friction. Receiving this award reinforces the importance of that work and the value of building logistics systems that can scale with emerging therapeutic modalities.  

This award also reflects the trust placed in us by clients across the globe. Their partnership and feedback continue to push us to refine our offerings, anticipate new challenges, and innovate in ways that align with the evolving needs of advanced therapy development.  

Receiving the Best Logistics & Supply Chain Management Supplier – Digital Technology & Software award is an honor and a motivator. It reinforces the responsibility we have to support the future of biopharma with systems and services that protect the integrity of every shipment and the potential of every therapy.  

We extend our appreciation to the awards committee and to all those who contribute to advancing excellence across the industry. And most importantly, we thank our Cryoport Systems teams and customers for the shared commitment that made this recognition possible.  

We look forward to building upon this momentum as we continue to grow our global footprint to support life-changing therapies worldwide.